MILPITAS, Calif., Jan. 04, 2017 -- IXYS Corporation (NASDAQ:IXYS) announced today that it will participate in the 19th Annual Needham & Company, LLC Growth Conference to be held in New York City on January 10-12, 2017.
Dr. Nathan Zommer, Founder and Chief Executive Officer of IXYS, will give the presentation on January 11, 2017 at 12:50-1:30 PM, Eastern Time.
An audio presentation can be accessed live by going to:
http://wsw.com/webcast/needham79/ixys
IXYS develops and markets primarily high performance power and RF semiconductors, microcontrollers and control ICs that are used in controlling and converting electrical power efficiently in power systems for telecommunication infrastructure, motor drives, medical systems and transportation. IXYS also serves emerging markets with digital and analog ICs that control flat panel displays, medical instruments and telecommunication products.
Additional information may be obtained by visiting IXYS’ website at http://www.ixys.com, or by contacting the company directly.
Contact: Uzi Sasson President & CEO Tel: 408-457-9000


Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking.
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Robinhood Expands Sports Event Contracts With Player Performance Wagers
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Shell M&A Chief Exits After BP Takeover Proposal Rejected
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation 



